Under this research agreement, RedHill will provide required drug quantities for animal studies, analytical support to quantify drug concentrations in plasma samples, and share dosing regimen with the Achanta Lab at Duke University.
Redhill Biopharma Signed A Collaborative Research Agreement With Duke University School Of Medicine Outlining Plans For Multiple In Vivo Studies, To Test Opaganib As A Potential Medical Countermeasure To Treat Phosgene Inhalation Injury
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated